Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2009

01-12-2009 | Short Research Report

Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service

Authors: Parastou Donyai, Melandi Van den Berg

Published in: International Journal of Clinical Pharmacy | Issue 6/2009

Login to get access

Abstract

Objectives We examined the characteristics and CHD risks of people who accessed the free Healthy Heart Assessment (HHA) service operated by a large UK pharmacy chain from August 2004 to April 2006. Methods Associations between participants’ gender, age, and socioeconomics were explored in relation to calculated 10-year CHD risks by cross-tabulation of the data. Specific associations were tested by forming contingency tables and using Pearson chi-square (χ2). Results Data from 8,287 records were analysable; 5,377 were at low and 2,910 at moderate-to-high CHD risk. The likelihood of moderate-to-high risk for a male versus female participant was significantly higher with a relative risk ratio (RRR) 1.72 (P < 0.001). A higher percentage of those in socioeconomic categories ‘constrained by circumstances’ (RRR 1.15; P < 0.05) and ‘blue collar communities’ (RRR 1.13; P < 0.05) were assessed with moderate-to-high risk compared to those in ‘prospering suburbs’. Conclusions People from ‘hard-to-reach’ sectors of the population, men and people from less advantaged communities, accessed the HHA service and were more likely to return moderate-to-high CHD risk. Pharmacists prioritised provision of lifestyle information above the sale of a product. Our study supports the notion that pharmacies can serve as suitable environments for the delivery of similar screening services.
Literature
4.
go back to reference Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.PubMed Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.PubMed
5.
go back to reference Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.CrossRefPubMed Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.CrossRefPubMed
7.
go back to reference Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109:1101–7.CrossRefPubMed Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation. 2004;109:1101–7.CrossRefPubMed
9.
go back to reference Purcell H, Daly C, Petersen S. Coronary heart disease in men (reversing the ‘descent of man’). In: Kirby R, et al., editors. Men’s health. London: Taylor & Francis; 2004. p. 101–9. Purcell H, Daly C, Petersen S. Coronary heart disease in men (reversing the ‘descent of man’). In: Kirby R, et al., editors. Men’s health. London: Taylor & Francis; 2004. p. 101–9.
Metadata
Title
Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service
Authors
Parastou Donyai
Melandi Van den Berg
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9338-4

Other articles of this Issue 6/2009

International Journal of Clinical Pharmacy 6/2009 Go to the issue